Intracardiac Echocardiography Guided Watchman Device Implant
Recruiting · Not applicable · NCT06007872
Conditions: Atrial Fibrillation, Left Atrial Appendage Thrombosis
At a glance
- Research payments reported, 2025
- $98,855
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 100
About the trial
- Sponsor
- The Cleveland Clinic
- Tested
- Intracardiac Echocardiography (ICE) (device)
- Dates
- Started 2022-12-02; completion 2027-12-31
- Results posted
- Not yet
This study is to look at the success of Intracardiac Echocardiography (ICE) in the Watchman procedure. Currently the process is to use a Transesophageal Echocardiography (TEE) to place the Watchman in patients. This study is aiming to show how the ICE is just as effective in placing the device correctly and effectively.
From ClinicalTrials.gov, last updated 2026-11-09. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Philips North America LLC reported $98,855 in research payments for this study in 2025 (4 payments).
Products named: Ice 3d
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.